EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model

Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer

(2015) Sara Zalba et al.   JOURNAL OF CONTROLLED RELEASE

Biological Barriers and Current Strategies for Modifying Nanoparticle Bioavailability

(2014) Andrew M. Prantner et al.   JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY

Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status

(2013) Roy van der Meel et al.   ADVANCED DRUG DELIVERY REVIEWS

Targeting colorectal cancer cells with single-walled carbon nanotubes conjugated to anticancer agent SN-38 and EGFR antibody

(2013) Pei-Chi Lee et al.   BIOMATERIALS

Epidermal growth factor receptor targeting in cancer: A review of trends and strategies

(2013) Chetan Yewale et al.   BIOMATERIALS

Liposomes, a promising strategy for clinical application of platinum derivatives

(2013) Sara Zalba et al.   Expert Opinion on Drug Delivery

Current trends in the use of liposomes for tumor targeting

(2013) Pranali P Deshpande et al.   Nanomedicine

Application of different methods to formulate PEG-liposomes of oxaliplatin: Evaluation in vitro and in vivo

(2012) Sara Zalba et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Targeting the EGFR signaling pathway in cancer therapy

(2012) Parthasarathy Seshacharyulu et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells

(2012) Christoph Mamot et al.   JOURNAL OF DRUG TARGETING

PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery

(2011) Paola Milla et al.   CURRENT DRUG METABOLISM

Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance

(2010) Murugan Kalimutho et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

The Effects of Particle Size and Molecular Targeting on the Intratumoral and Subcellular Distribution of Polymeric Nanoparticles

(2010) Helen Lee et al.   MOLECULAR PHARMACEUTICS

Efficient gene delivery by EGF-lipoplexesin vitroandin vivo

(2010) María Buñuales et al.   Nanomedicine

Dendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug delivery

(2010) Quan Yuan et al.   ORAL ONCOLOGY

Targeted Killing of Cancer Cells in Vivo and in Vitro with EGF-Directed Carbon Nanotube-Based Drug Delivery

(2009) Ashwin A. Bhirde et al.   ACS Nano

Targeting of Epidermal Growth Factor Receptor (EGFR)-Expressing Tumor Cells with Sterically Stabilized Affibody Liposomes (SAL)

(2009) Julia Beuttler et al.   BIOCONJUGATE CHEMISTRY

Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy

(2009) E. Martinelli et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Membrane-anchored growth factors, the epidermal growth factor family: Beyond receptor ligands

(2008) Shigeki Higashiyama et al.   CANCER SCIENCE

Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo

(2008) Shuxian Song et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Targeted Tumor Cell Internalization and Imaging of Multifunctional Quantum Dot-Conjugated Immunoliposomes in Vitro and in Vivo

(2008) Kevin C. Weng et al.   NANO LETTERS

Cetuximab inhibits thymidylate synthase in colorectal cells expressing epidermal growth factor receptor

(2008) Sergej Skvortsov et al.   Proteomics Clinical Applications